Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

869
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
869
Liver Physiology01:30

Liver Physiology

880
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
880
Hepatic Portal System01:21

Hepatic Portal System

1.7K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
1.7K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

181
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
181
Gross Anatomy of the Liver01:17

Gross Anatomy of the Liver

756
The liver, the largest gland within the human body, is a firm and reddish-brown organ. This wedge-shaped structure weighs approximately 1.5 kg and occupies a significant portion of the right hypochondriac and epigastric regions. It extends more to the right of the body's midline than to the left.
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is...
756
Liver Regeneration01:24

Liver Regeneration

3.3K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Viscoelastic Tests in Cirrhotic Patients Undergoing Invasive Procedures: A Systematic Review and Meta-Analysis of RCTs.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Safe Prostatic Artery Embolization with Cyanoacrylate: Representative Cases Demonstrating Non-Target Artery Preservation.

Diagnostics (Basel, Switzerland)·2026
Same author

Primary biliary cholangitis: current insights and novel therapies.

Expert review of clinical immunology·2026
Same author

The application of Artificial Intelligence in the ultrasound-based diagnosis of liver disease: current status, hurdles, and prospects.

Ultraschall in der Medizin (Stuttgart, Germany : 1980)·2026
Same author

Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma.

Cells·2026
Same author

Letter: Double PBC-Related Autoantibody Positivity-How Essential Is It for Diagnosis?

Alimentary pharmacology & therapeutics·2026

Related Experiment Video

Updated: Aug 13, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.3K

COVID-19: Has the Liver Been Spared?

Nicolò Brandi1, Daniele Spinelli1, Alessandro Granito2

  • 1Department of Radiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, 40138 Bologna, Italy.

International Journal of Molecular Sciences
|January 21, 2023
PubMed
Summary

The COVID-19 virus can harm the liver, worsening chronic liver disease and complicating treatment for cirrhosis and liver tumors. Telemedicine offers solutions for managing these patients during the pandemic.

Keywords:
COVID-19chronic liver diseasehepatocellular carcinomalivermanagement

More Related Videos

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K
The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

9.5K

Related Experiment Videos

Last Updated: Aug 13, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.3K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K
The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

9.5K

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Oncology

Background:

  • The liver is a secondary target of COVID-19, leading to significant complications.
  • COVID-19 exacerbates pre-existing chronic liver disease, increasing risks of hepatic decompensation.
  • The pandemic impacts management of decompensated cirrhosis, hepatocellular carcinoma (HCC), and follow-up care.

Purpose of the Study:

  • To review hypothesized pathophysiological mechanisms of COVID-19-induced liver injury.
  • To analyze the pandemic's consequences on patients with chronic liver disease and liver tumors.
  • To evaluate management strategies for liver disease patients during the COVID-19 emergency.

Main Methods:

  • Literature review of COVID-19's effects on liver disease.
  • Analysis of direct viral invasion and indirect effects on liver injury.
  • Examination of pandemic-related challenges in liver disease management.

Main Results:

  • COVID-19 can directly cause liver complications and indirectly affect patient management.
  • Liver imaging in COVID-19 is nonspecific but aids in identifying complications.
  • Telemedicine presents a viable strategy for overcoming pandemic-related healthcare challenges.

Conclusions:

  • Understanding COVID-19's multifaceted impact on liver health is crucial.
  • Improved management strategies are needed for chronic liver disease and liver tumor patients.
  • Telemedicine can enhance care continuity and accessibility during health crises.